Download Your Copy of the Agenda
The 8th RNAi-Based Therapeutics Summit is the industry's dedicated forum for advancing extrahepatic RNAi delivery, improving therapeutic potency and safety, and expanding RNAi applications across high-value disease indications. Download the agenda to explore the full speaker faculty, workshops, panels, case studies and networking opportunities.
90+ RNAi Experts Under One Roof
Connect with RNAi leaders from Eli Lilly and Company, Bayer, Novo, Sanegene Bio, Judo Bio, Thalia Therapeutics, and beyond.
Advance RNAi Delivery Beyond the Liver
Explore emerging approaches to achieve selective, durable delivery across the CNS, muscle, heart, adipose tissue, kidney, retina, and tumors.
Optimize Potency, Safety & Therapeutic Index
Discover how developers are improving oligonucleotide chemistry, PK/PD performance, dosing, specificity, and endosomal escape to create safer and more effective RNAi therapies.
Expand RNAi Into High-Value Indications
Gain disease-specific insights spanning obesity, metabolic and cardiovascular disease, neurology, oncology, ophthalmology, and other areas of unmet need.
Explore the Future of RNAi Innovation
Evaluate next-generation technologies including aptamer-siRNA conjugates, tetravalent siRNAs, nanoparticles, bispecific RNAi, and dual- and multi-gene silencing strategies.
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
Attending Companies Include
